HOME >> BIOLOGY >> NEWS
Brazil's first oncology biotech launches

(New York, June 14)--Recepta, Brazil's first oncology biotechnology company was launched today by PR&D, a Brazilian venture capital company, and the international non-profit Ludwig Institute for Cancer Research (LICR). The company will explore the therapeutic potential of three antibodies discovered and characterized by LICR.

One of the antibodies in Receptas portfolio is expected to enter clinical trials this year. Internal review board permission has been granted by So Paulos Oswaldo Cruz German Hospital (HAOC), one of the centers of clinical excellence in Brazil, to conduct a clinical trial assessing the antibodys efficacy for patients with resected ovarian cancer. This will be the first phase II oncology clinical trial sponsored by a Brazilian company. Recepta will conduct preclinical work with investigators at the So Paulo Branch of LICR, which is based at HAOC.

According to the director of Recepta, Dr. Jos Fernando Perez, the company has benefited greatly from the international collaborations and support provided by LICR. Its important to appreciate that the Ludwig Institute is more than simply a share-holder in Recepta. This is a partnership that involves Ludwig Institute investigators from around the world contributing their knowledge and expertise to assist Receptas development efforts. Dr. Perez, who is the former director of FAPESP (State of Sao Paulo funding body), says that the partnership between LICR and PR&D evolved from an institutional partnership formed by LICR and FAPESP in the 1990s. That partnership created the internationally acclaimed ONSA (Organization for Nucleotide Sequencing and Analysis) and Human Cancer Genome Project (HCGP), state- and nation-wide sequencing programs, respectively, that brought Brazilian genomics to the worlds attention.

LICR's senior scientific officer, Dr. Andrew Simpson, who was a key player in ONSA and HCGP, says that the development of Recepta re-emphasizes the Institutes belief i
'"/>

Contact: Sarah L. White
swhite@licr.org
917-379-0398
Ludwig Institute for Cancer Research
14-Jun-2007


Page: 1 2

Related biology news :

1. Report shows deforestation threatens Brazils Pantanal
2. Selective logging causes widespread destruction of Brazils Amazon rainforest, study finds
3. Saudi Arabias KAUST names WHOI first research partner
4. Which came first, the moth or the cactus?
5. In a first, Einstein scientists discover the dynamics of transcription in living mammalian cells
6. Seawater intrusion is the first cause of contamination of coastal aquifers
7. Camera-shy deer caught for first time
8. CTRC enrolls first patients in novel phase II study for sarcoma -- living virus destroys cancer cell
9. New joint replacement material developed at MGH put to first clinical use
10. Liverpool amongst first in UK to install unique DNA sequencing technology
11. A first-principles model of early evolution

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/21/2019)... ... August 20, 2019 , ... ... bioactive technologies for the spine, today announced the 510(K) clearance of its novel ... modification that is proven to improve osseointegration through superior hydrophilicity and optimized surface ...
(Date:8/19/2019)... ... August 19, 2019 , ... Since ... use of ultra-thin two dimensional slices which are placed on microscope slides, stained ... complex tissues and complicated features such as vasculature and thus researchers in the ...
(Date:8/15/2019)... , ... August 15, 2019 , ... ... Now what? As serialization mandates become increasingly complex, and aggregation becomes fully applied ... serialization software is the best long-term solution. , Until now, most regulations?including the ...
Breaking Biology News(10 mins):
(Date:6/26/2019)... ... June 26, 2019 , ... Alice Branton today released research results from ... of Magnesium Gluconate, which can prove to be beneficial for treating Hypomagnesemia. , The ... peak, change in crystallite size , Over 142% increase in particle size ...
(Date:6/18/2019)... , ... June 18, 2019 , ... Personalized Stem ... New Drug (IND) application to the FDA for use of a person’s own adipose-derived ... a treatment of osteoarthritis in the knee. This IND is the first of ...
(Date:6/11/2019)... MONTREAL (PRWEB) , ... June 10, 2019 , ... ... growth of its distribution network with the appointment of Biofeedback Tech Ltd ... physiological monitoring systems are an essential part of many therapeutic treatments and clinical ...
(Date:6/11/2019)... ... June 10, 2019 , ... DeepDyve ... its scientific journals to DeepDyve’s rental service for peer-reviewed journals. , IOPP’s ... of more than 20 million articles, sourced from more than 15,000 journals. , ...
Breaking Biology Technology:
Cached News: